NDC 70771-1685
Nelarabine
Nelarabine
Nelarabine is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Cadila Healthcare Limited. The primary component is Nelarabine.
| Product ID | 70771-1685_3fdea8e8-07e5-41bc-964d-34b7a82e24f1 |
| NDC | 70771-1685 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Nelarabine |
| Generic Name | Nelarabine |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2021-11-17 |
| Marketing Category | ANDA / |
| Application Number | ANDA215037 |
| Labeler Name | Cadila Healthcare Limited |
| Substance Name | NELARABINE |
| Active Ingredient Strength | 5 mg/mL |
| Pharm Classes | Nucleoside Metabolic Inhibitor [EPC],Nucleic Acid Synthesis Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |